Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Akebia Therapeutics, Inc. (AKBA)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   8-K10-Q8-K10-Q10-Q10-K10-Q10-Q
Net income     -163.4-275.7-282.8-299.2-299.6
Depreciation and amortization   [+]   37.837.938.036.233.4
Asset impairment charges     17.615.915.68.615.4
Stock-based compensation     21.721.322.724.225.2
Change in working capital   [+]   -127.8-100.3-119.3-80.2-38.6
Other operating activities     42.897.172.889.472.3
Cash from operations     -171.4-203.8-253.0-220.9-191.9
   
Capital expenditures     -0.1-0.1-0.1-0.4-0.3
Sales of short-term investments         50.0
Cash from investing     -0.119.939.999.649.7
   
Issuance of common stock, net     28.666.188.293.377.2
Option exercises     0.80.7 0.7 
Other cash from financing     41.641.5 66.3 
Cash from financing     69.4106.8133.7158.8143.4
   
Free cash flow     -171.5-204.0-253.0-221.3-192.2
        Per share (diluted)     ($0.97)($1.20)($1.55)($1.41)($1.29)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy